Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide.
Biomedicines. 2022 Aug 31;10(9):2145. doi: 10.3390/biomedicines10092145.
Biomedicines. 2022.
PMID: 36140245
Free PMC article.